Exploring Second Line Treatments for Extensive Stage Small Cell Lung Cancer

In this episode, Dr. David Waterhouse and Dr. Paul Conkling discuss the evolving landscape of second line treatments for extensive stage small cell lung cancer (SCLC). They review the latest research, promising therapies, and the impact of these treatments on patient quality of life. This episode offers vital information to help navigate treatment options and empower patients. Don’t miss this engaging discussion on a crucial topic in oncology, filled with expert insights! Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.